SFTPD and acute respiratory distress syndrome: In the future, we can imagine an even more individualized therapy by using genomic approaches or biomarkers of ARDS severity and type: the surfactant adsorption test [63–65] and the surfactant protein-D assay [66, 67] are two of the most advanced tools in this field.